- Ask questions to help learn about their condition
- Welcome new members of the community
- Keep your health profiles updated, such as disease progress, symptoms, and treatments
- Share your opinions with others with consideration
- Respect confidentiality and don’t transmit other members’ information outside of the My Compassion community
- Healthy debate on the forum while sticking to the argument rather than making comments directed at an individual user
- Check in on members, make sure they’re OK and help them to keep their profiles accurate and up-to-date
- Share experiences without trying to provide medical advice
- Feedback to the My Compassion Team about potential improvements, questions, or comments about the site
When one is in danger it is known that one experiences fear. This level of fear triggers split second preparation for the body to defend itself against the danger. The "fight or flight" response is a normal healthy reaction meant for the body's protection but in post traumatic stress disorder this particular reaction is damaged and changed where a PTSD patient actually gets more stressed and frightened even when there is no danger.
PTSD develops usually after a extremely terrifying event that involved physical or mental harm and could be in the form of occuring to a loved one or being a participant in a harmful event. PTSD can be caused by a variety of traumatic incidents such as war, plane crashes, accidents, natural disasters, rape, bombings, abuse, kidnapping or hostage situation.
Some of the signs and symptoms of PTSD can be bad dreams, frightening thoughts, flashbacks, avoidance, or hyperarousal.
In recent discoveries it has been found that cannabidiol (CBD) can reduce anxiety, pacifies the nervous system and induces a state of relaxation without the challenging affects of THC on the psyche.
Nail patella syndrome is a genetic disorder which occurs at birth or during early childhood which lead to improper development, underdevelopment of the knee caps, underdevelopment of bones or abnormal projections of either side of the hipbone. Some may have increased pressure in the eyes leading to glaucoma.
Multiple sclerosis is an unpredictable disease that robs individuals of their independence and overall quality of life. Here in the Greater Delaware Valley, over 14,000 individuals are affected by MS with more than 2.1 million affected worldwide. The National MS Society through its network of chapters across the U.S. is leading the movement to stop MS in its tracks, restore function lost to the disease and end MS forever.
Multiple sclerosis is a chronic disease of the central nervous system. People with MS are usually diagnosed between the ages of 20-50 and face unpredictable symptoms that can include numbness, blurred vision, paralysis and blindness.
As we celebrate National MS Awareness Week, March 11-17, the Society encourages all local residents to reach out to their personal connections and ask them to join the movement against MS.
It has been discovered that cannabinoids reduce neuroinflammation with AMPA-induced excitotoxicity, as evaluated within multiple sclerosis. It has also been discovered that cannabigerol will alleviate neuroinflammation in multiple sclerosis. Cannabidiol has also demonstrated antioxidant with anti-inflammatory effects
Those who are qualified for taking cannabinoids with this condition can utilize a variety of product types for relief from smokable form, extracts, vaporizing, tinctures, lotions, drinkables and edibles.
Hepatitis C is a contagious disease of the liver which is caused by the hepatitis C virus (HCV). Most become infected by direct contact with blood from a patient who is already infected through the sharing of needles or sometimes from sexual contact. It is estimated 3.4 million Americans have chronic hepatitis C. Hepatitis C can become a chronic infection that will lead to liver cancer.
Some of the symptoms of hepatitis C are loss of appetite, nausea, abdominal pain, fatigue and joint pain all of which cannabinoids can help reduce in multiple product types from extracted oil, vaporizing and medible formats.
Based on a recent research study cannabinoids helped improve the effectiveness of various types of drug therapy for hepatitis C. It also showed that smoking cannabinoids made it more effective in reaching the objective of a sustained virological response which is considered a huge success with the disease not being found anywhere in the body.
Crohn's patients seek cannabinoid approvals because they have already found that it changes the course of their disease. After seeing the first several patients reporting marked improvement in their conditions with the use of cannabinoids other groups began reporting the same significant change.
All surveyed patients with Crohn's disease report statistically significant improvement in signs and symptoms in all categories: pain in the gut, anorexia, nausea, vomiting, fatigue, depressed mood, and activity level. Based on a recent Israeli clinical study cannabinoids reduced pain in the gut more so than the pharmaceuticals that were provided. The number of stools per day was reduced, the body weight increased, and all patients reported the frequency and severity of flare-ups were reduced. Through the use of hemp many have seen these side effects reduce or completely become eliminated as the patient begins to embrace cannabinoid therapeutics.
It is now known that biopsy specimens from Crohn's patients had large quantities of cannabinoid receptors. Activating these receptors with cannabinoids promoted healing of the gastrointestinal membrane. This could offer therapeutic relief to patients suffering from inflammatory disorders such as Crohn's disease and ulcerative colitis.
Cannabinoid types of products that are available for Crohn’s disease patients credits raw cannabinoid juice, vaporizing and eating GMO free medible foods.
Living with chronic pain should be enough of a burden for anybody. But pile on depression -- one of the most common problems faced by people with chronic pain -- and that burden gets even heavier. Depression can magnify pain and make it harder to cope. The good news is that chronic pain and depression aren't inseparable. Effective treatments can relieve depression, migraines and can help make chronic pain more tolerable.
If you have chronic pain and depression, you've got plenty of company. That’s because chronic pain and depression are common problems that often overlap. Depression is one of the most common psychological issues facing people who suffer from chronic pain, and it often complicates the patient's conditions and treatment.
Because depression in patients with chronic pain frequently goes undiagnosed, it often goes untreated. Pain symptoms and complaints take center stage on most doctors' visits. The result is depression, along with sleep disturbances, loss of appetite, lack of energy, and decreased physical activity which may make pain much worse. One of the best things for chronic pain is juicing cannabis.
"Chronic pain and depression go hand in hand," says Steven Feinberg, MD, adjunct associate clinical professor at Stanford University School of Medicine. "You almost have to assume a person with chronic pain is depressed and begin there." Pain provokes an emotional response in everyone. Anxiety, irritability, and agitation -- all these are normal feelings when we're hurting. Normally, as pain subsides, so does the stressful response.
But what if the pain doesn't go away? Over time, the constantly activated stress response can cause multiple problems associated with depression. Those problems can include:
• Chronic anxiety
• Confused thinking
• Sleep disturbances
• Weight gain or loss
Cannabinoids have shown therapeutic properties that can simultaneously modulate many of the other opioid medications that are currently prescribed to chronic pain patients and far less side effects of opioid deaths.
Cachexia also known as wasting syndrome with symptoms of significant loss of appetite, loss of weight, weakness, fatigue, and muscle atrophy in a patient that is not attempting to lose weight. This type of reduction in body mass will not be reversed nutritionally. Cachexia is primarily seen with patients who are suffering from cancer, AIDS, COPD, multiple sclerosis, tubercolosis, and familial amyloid neuropathy.
Patients suffering from cachexia can experience the chance of death. Cachexia physically weakens patients to no mobility from the loss of appetite, anemia and response to regular treatment is very poor. Cachexia tends to happen more in end-stage cancer which is also known as cancer cachexia. It is also associated with advanced stage of multiple sclerosis, motor neuron disease, Parkinson's disease, dementia, HIV/AIDS and other illnesses.
Medical marijuana or cannabis has been allowed for the treatment of cachexia in a number of U.S. states, such as Arizona, California, Colorado, Connecticut, Delaware, Michigan, New Jersey, New Mexico, Nevada, Rhode Island, Washington, and Vermont.
Of cancer patients 50% suffer from cachexia with those that have upper gastrointestinal and pancreatic cancers having the highest frequency of the development of a cachexic symptom. It rises to over 90% in terminal cancer patients. On top of increased morbidity and mortality, the aggressive side effects of chemotherapy, reduced quality of life, cachexia is considered to be the cause of death to a large number of cancer patients, from 25% - 50%.
Cancer cachexia symptoms include progressive weight loss and host reserves of adipose tissue and skeletal muscles. Traditional treatment options are appetite stimulants such as cannabinoids for cachexia have been used to increase weight on cachexic patients.
In clinical studies THC effects on cachexia has been seen to produce significant stimulation of appetite and increased body weight in HIV positive and cancer patients. Cannabinoids as a whole is better tolerated than THC by itself as it is combined with cannabidiol (CBD), which antagonize the psychotropic effects of THC, and do not inhibit the appetite-stimulating effect.
Cannabinoids also show a antiemetic effect in chemotherapy-induced nausea/vomiting. With cannabinoids offering improvements over modern antiemetic medication. It is noted that can-na-bis has been a appetite stimulant since as far back as 300 A.D. During the 19th century, doctors mentioned the increase of appetite after using kan-na-bis.This particular cause decreased the amount of pharmaceuticals prescribed for chemotherapy induced nausea and vomiting.
Alzheimer's disease is the most common type of dementia. Symptoms of Alzheimer's, including early-onset Alzheimer's, include problems with memory, judgment and thinking, which makes it hard to work or take part in day-to-day life. As the stages of Alzheimer's progress, memory loss and other signs of Alzheimer's become more apparent. Many people find help with Alzheimer's drugs, but there is no cure for this form of dementia.
The following signs are considered Alzheimer's disease 'warning signs' that should prompt an evaluation by a healthcare professional.
• Memory loss
• Language problems
• Difficulty in performing familiar tasks
• Poor judgment
• Misplacing items
• Rapid mood swings
• Personality changes
• Increased apathy or passiveness
According to the research study at the Scripps Research Institute THC was found to inbibit acetylcholinesterase which tends to act as a attached molecule which accelerates the formation of amyloid plaque for victims who suffer from Alzheimer's Disease.
This particular disease is one of the ailments that can use cannabinoids for therapeutic treatment which is protected by cannabinoid states across the United States.
In the mid-1980s people with AIDS discovered that cannabinoids relieved the nausea caused by their illness or by the medications taken to combat it. In addition, cannabinoids often improved their appetite and enabled them to stop losing or even to gain weight. Like most medical users of cannabinoids, AIDS patients have found that smoked cannabinoids has specifically been advocated than Marinol (dronabinol), a synthetic THC developed by a small pharmaceutical company, Unimed, with considerable financial support from the government. The federal authorities had come to believe that its availability would quell demands of herbal marijuana as a medicine.
The prevalence of pain in patients living with HIV/AIDS has been estimated at 60%. Pain interferes with daily living and is a marker for reduced survival. While pain associated with HIV/AIDS is well documented, it is often underrecognized and undertreated in clinical practice.
Painful conditions associated with HIV infection include pain due to headache, herpes simplex, peripheral neuropathy, back pain, herpes zoster, throat pain, and arthralgia. In addition, clinical experience suggests an increasing incidence of pain due to malignancies and associated treatments.
A study done by Dr. Donald Abrams found that smoked cannabis was effective at reducing painful HIV-associated neuropathy, as well as effective at reducing pain from a heat-capsaicin model of peripheral neuropathy.
Nausea is one of the main reasons for cannabis use by persons with HIV/AIDS. The ability of cannabinoid receptor areas to treat nausea has been recognized for a long time; the oldest prescription cannabinoids (dronabinol and nabilone) were approved for the treatment of nausea and vomiting following chemotherapy.
The effects of THC on appetite and weight were evaluated in 88 patients with AIDS related anorexia and weight loss. THC was associated with increased appetite, improvement in mood, and decreased nausea. The effects of cannabinoids on appetite, have shown that oral THC improves appetite and reverses weight loss. THC also showed a positive effect on sleep.
Glaucoma is a chronic condition that causes damage to the eye's optic nerve and progressively gets worse. The damage occurs though a buildup of pressure inside the eye and normally doesn't show up till later on in life. The pressure is called intraocular pressure can damage the optic nerve and cause permanent loss of vision within a few years.
It has been discovered that Delta 9 - THC in the form of a topical application as in eye drops have been far less more effective than smoked cannabinoids. During a recent discovery of cannabinoid receptors located in the ocular area which has stimulated new research in the development of a topical eye drop form which would minimize the psychological effects of cannabis sativa.
Cannabinoids have been shown to decrease intraocular pressure for brief periods of time with consistent use of cannabinoids in smoking, vaporizing and ingesting cannabinoid oil form. Some of the new delivery methods are extended release oral capsules where there is improved cannabinoids that work with other medications or cannabinoids other than THC such as cannabidiol (CBD).
Epilepsy is a chronic condition disorder in which the brain produces seizures. This type of seizure are not caused by other medical conditions such as high fevers or brain injuries. Epilepsy has the ability to affect patients in a variety of ways because there could be many reasons and many kinds of seizures. Some patients may have a variety of seizures or other chronic conditions on top of epilepsy. All of these factors play a dominant role in the severity of the patient's condition and the impact epilepsy will have on their lives.
A seizure can produce varying side effects such as causing a patient to fall, have staring spells, shake, and in many cases become unaware of what is happening around them. Epilepsy can be caused by other conditions that affect the brain like strokes, brain tumors, central nervous system infection or traumatic brain injuries (TBI).
According to the latest statistics 2% of adults aged 18 years or older have been diagnosed with epilepsy or seizure disorder which is about 4.3 million adults and 750,000 children aged 0-17 years based on the population stats for 2013.
The total cost of epilepsy in the U.S. is estimated to be at $16 billion annually.
As news spreads of children and adults with uncontrollable epilepsy being provided cannabidiol (CBD) - a non-psychoactive ingredient and other types of medical cannabis strains, desperate parents and patients have created an outcry for more research, information and potentially a chance to attempt these treatments.
My Compassion believes that the serious long-term effects of synthetic anti-epileptic pharmaceuticals with a lifetime of unrelenting seizures cannot be set aside. The positive outcomes that some patients like Kimberly Cole and Noah Smith have been seeing with cannabinoid extracts are giving many patients and parents the hope they have been wishing.
Many epilepsy patients have tried countless number of medications, invasive electrical stimulation devices, brain operations, alternative therapies and dietary changes with inconsistent relief of their symptoms. Shouldn't cannabinoids then become a viable natural alternative choice when no other treatments work?
My Compassion believes that cannabinoids provide a increase in the quality of life for patients, parents and families. My Compassion is committed to helping patients, caregivers, parents, doctors and researchers overcome the obstacles to advanced research in this area.My Compassion understands that cannabinoids or CBD enriched strains may not be the only answer and that much more needs to be done in finding treatments and a cure for all forms of epilepsy and seizures. Current epilepsy cannabinoid patients are encouraged that this may become a promising treatment presently and into the future. My Compassion researchers will be testing pure THC and CBD as well as high CBD / low THC, high THC / low CBD and other types of cannabinoid compounds on epilepsy in order to clearly define cannabinoid effects on seizure control and epilepsy.
Cancer is related to chronic set of diseases that can start almost anywhere in the body whereby cells in the body begin to divide and spread into surrounding tissue through killing healthy cells. A normal cell usually grow and divide to form new healthy cells as the body requires them. In the case of cancer the orderly process of healthy cells aging or damaged cells dying, the cells become mutated forcing old or damaged cells to survive and not die while new cells continue to form when they are not quite needed yet. The extra cells will divide without stopping forming into growths called tumors.
Large number of cancers form solid tumors while blood cancer types such as leukemias do not form solid tumors.
To find a list of cancer types see the list here.
Cannabinoids have helped increase the quality of life for a large number of cancer patients around the world from nausea, vomiting, reducing pain and inflammation, fighting the side effects of chemotherapy and increasing appetite.
The National Cancer Institute admitted that marijuana kills cancer cells in their recent article where they stated that THC slowed the growth of lung cancers, breast cancers, and virus-induced leukemia..." and "prolonged their lives by as much as 36%."
Dr. Manuel Guzman from Madrid's Complutense University discovered that THC could selectively induce programmed cell death in brain tumor cells with impacting healthy cells. In 2012 a pair of scientists found THC stops metastasis in many kinds of agressive types of cancer as per the California Pacific Medical Center.
In recent years a large number of research studies and scientific reports on cannabis and cancer have appeared with incredible testimonials from young patients to seniors desiring to increase the quality of life and seeing further healing.
Stories like Alysa Erwin who suffered from anaplastic astrocytoma and utilized canna oil with a combination of can-na-bis product types to help the effects of cancer, radiation and surgery. Even when she stopped taking the preventative maintenance dose of cannabinoids and the cancer came back into her ventricles, brain stem and spinal fluids. She decided for a second time to utilize canna oil this time in the hospital with the acknowledgement of her doctors, "Keep doing what you're doing." She is cancer free once again at age 19 with her first diagnosis occurring at the tender age of 14.
Cancer patients are starting to spread the education and compassion of how cannabis helped their cancer by recommending MJ to patients by becoming pro-active with their doctors by having a true heart to heart with facts, research and testimonials with a combination of other alternative treatment techniques and supplements. This way of instruction will not only help their doctors be educated in cannabinoids but will assist future cancer patients who may begin asking about cannabinoids as a viable cancer treatment.